Evidence map›Paper›PMID 24733308›Full record

ArticlePloS one2014

Zebrafish on a chip: a novel platform for real-time monitoring of drug-induced developmental toxicity.

Yinbao Li, Fan Yang, Zuanguang Chen, Lijuan Shi, Beibei Zhang, Jianbin Pan, Xinchun Li, Duanping Sun, Hongzhi Yang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Engineered platforms for mimicking cardiac development and drug screening.Cellular and molecular life sciences : CMLS · 2024
    Review
  4. A 1, 4-benzoquinone derivative isolated fromSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Microfluidics for interrogating live intact tissues.Microsystems & nanoengineering · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yinbao LiSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China; School of Pharmaceutical Sciences, Gannan Medical University, Ganzhou, JiangXi, China.
Fan YangSchool of Laboratory Medcine, Hubei University of Chinese Medicine, Wuhan, China.
Zuanguang ChenSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
Lijuan ShiSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
Beibei ZhangSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
Jianbin PanSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
Xinchun LiSchool of Pharmaceutical Sciences, Guangxi Medical University, Nanning, China.
Duanping SunSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
Hongzhi YangThe third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Sun Yat-sen University · CNGuangxi Medical University · CNHubei University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pharmaceutical safety testing requires a cheap, fast and highly efficient platform for real-time evaluation of drug toxicity and secondary effects. In this study, we have developed a microfluidic system for phenotype-based evaluation of toxic and teratogenic effects of drugs using zebrafish (Danio rerio) embryos and larvae as the model organism. The microfluidic chip is composed of two independent functional units, enabling the assessment of zebrafish embryos and larvae. Each unit consists of a fluidic concentration gradient generator and a row of seven culture chambers to accommodate zebrafish. To test the accuracy of this new chip platform, we examined the toxicity and teratogenicity of an anti-asthmatic agent-aminophylline (Apl) on 210 embryos and 210 larvae (10 individuals per chamber). The effect of Apl on zebrafish embryonic development was quantitatively assessed by recording a series of physiological indicators such as heart rate, survival rate, body length and hatch rate. Most importantly, a new index called clonic convulsion rate, combined with mortality was used to evaluate the toxicities of Apl on zebrafish larvae. We found that Apl can induce deformity and cardiovascular toxicity in both zebrafish embryos and larvae. This microdevice is a multiplexed testing apparatus that allows for the examination of indexes beyond toxicity and teratogenicity at the sub-organ and cellular levels and provides a potentially cost-effective and rapid pharmaceutical safety assessment tool.

Indexed as

Computer SystemsAminophyllineAnimalsEmbryonic DevelopmentEmbryo, NonmammalianFertilizationHeart Defects, CongenitalHeart RateLarvaMicrofluidicsRheologySeizuresSurvival AnalysisTeratogensToxicity TestsZebrafishAminophyllineTeratogens

Identifiers

PMID24733308
PMCPMC3986246
OpenAlexW2329648100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.